What if a single vaccine could offer protection against a range of disease-causing bacteria, common allergens and respiratory viruses? A new mouse study highlights an experimental vaccine that could potentially offer that elusive “universal” protection.
As it’s been tested only in lab animals, the vaccine must still pass a number of trials in people before it can be proven safe and effective.
Conventionally, vaccines train the immune system to recognize a specific antigen, such as a protein on a virus’s surface. The immune system then trains cells to remember and attack that antigen if they encounter it. This results in a robust, but fairly narrow immune defense — one which can be thwarted if the target antigen mutates over…




